SCHEMBL9998671

SCHEMBL9998671

CCCCCCCC(CC)c1c(C)cccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR5 P32302 2/20 0.49
ALDH1A1 P00352 2/20 0.48
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
CYSLTR2 Q9NS75 2/20 0.43
CYSLTR1 Q9Y271 2/20 0.43
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
SLC37A4 O43826 1/20 0.40
MEN1 O00255 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
RARB P10826 1/20 0.39
NR1I2 O75469 1/20 0.39
MYC P01106 1/20 0.39
PTPN11 Q06124 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10936470 0.90 ALDH1A1 (0.50) CXCR5ALDH1A1PRSS1PRSS2PRSS3
SCHEMBL5609680 0.88 CXCR5 (0.59) CXCR5ALDH1A1CYSLTR2CYSLTR1KDM4E
SCHEMBL27958078 0.85 ALDH1A1 (0.55) ALDH1A1PRSS1PRSS2PRSS3CYSLTR2
SCHEMBL8147781 0.83 ALDH1A1 (0.50) CXCR5ALDH1A1PRSS1PRSS2PRSS3
SCHEMBL9903580 0.81 ALDH1A1 (0.43) CXCR5ALDH1A1PRSS1PRSS2PRSS3
SCHEMBL30438055 0.81 ALDH1A1 (0.48) ALDH1A1PRSS1PRSS2PRSS3CYSLTR2
SCHEMBL9998672 0.81 ALDH1A1 (0.48) ALDH1A1PRSS1PRSS2PRSS3CYSLTR2
SCHEMBL27963993 0.79 KDM4E (0.45) CXCR5ALDH1A1KDM4ERARBNR1I2
SCHEMBL27838149 0.79 KDM4E (0.47) ALDH1A1CYSLTR2CYSLTR1KDM4EHPGD
SCHEMBL671032 0.78 ALDH1A1 (0.55) ALDH1A1PRSS1PRSS2PRSS3CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582701-B1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE ALTOS THERAPEUTICS LLC (US) 2016-11-02 EP disclosed
EP-2582701-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2013-04-24 EP disclosed
WO-2011160084-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2011-12-22 WO disclosed